In Mouse Model, Small Peptide Ameliorates Autoimmune Skin Blistering DiseaseMain Category: Immune System / Vaccines
Also Included In: Dermatology
Article Date: 10 Jan 2013 - 1:00 PST
In Mouse Model, Small Peptide Ameliorates Autoimmune Skin Blistering Disease
|Patient / Public:|
5 (1 votes)
Pemphigus vulgaris is a life-threatening autoimmune skin disease that is occurs when the body's immune system generates antibodies that target proteins in the skin known as desomogleins.
Desmogleins help to form the adhesive bonds that hold skin cells together and keep the skin intact.
Currently, pemphigus vulgaris is treated by long-term immune suppression; however, this can leave the patient susceptible to infection.
In this issue of the Journal of Clinical Investigation, researchers led by Jens Waschke at the Institute of Anatomy and Cell Biology in Munich, Germany, report on a small peptide that blocked antibody recognition of desmogleins. Importantly, the peptide could prevent antibody-mediated skin blistering when applied topically to mice. At the cellular level, the peptide improved cell-cell adhesion and attenuated signaling pathways that are activated by antibody binding. These results suggest that this peptide could serve as a treatment option for pemphigus vulgaris.
TITLE: Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering
View this article at: http://www.jci.org/articles/view/60139?key=b333192372ea9937c9be
Visit our immune system / vaccines section for the latest news on this subject.
22 May. 2013. <http://www.medicalnewstoday.com/releases/254764.php>
Please note: If no author information is provided, the source is cited instead.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.